Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. (ORIC) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 158 transactions totaling $50.2M, demonstrating a bearish sentiment with -$25.5M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 40,000 shares valued at $0.
ORIC Insider Activity Summary
Who Is Buying ORIC Stock?
No significant insider buying has been recorded for ORIC in the recent period.
Who Is Selling ORIC Stock?
No significant insider selling has been recorded for ORIC in the recent period.
Is Oric Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ORIC is bearish with an Insider Alignment Score of 25/100 and a net flow of -$25.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ORIC Frequently Asked Questions
Understanding ORIC Insider Activity
Insider trading at Oric Pharmaceuticals, Inc. (ORIC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading ORIC stock, having executed 158 transactions in the past 90 days. The most active insider is Carl L. Gordon (Executive), who has made 18 transactions totaling $19.7M.
Related Tools
Track Oric Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ORIC file new Form 4 transactions